PEDMARK is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fennec Pharmaceuticals Inc.. The primary component is Sodium Thiosulfate.
| Product ID | 73077-010_b7f09611-0c5e-43bb-8dee-900634076dc9 |
| NDC | 73077-010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PEDMARK |
| Generic Name | Sodium Thiosulfate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-10-03 |
| Marketing Category | NDA / |
| Application Number | NDA212937 |
| Labeler Name | Fennec Pharmaceuticals Inc. |
| Substance Name | SODIUM THIOSULFATE |
| Active Ingredient Strength | 13 g/100mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-10-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 73077-010 | PEDMARK | SODIUM THIOSULFATE |
| 60267-705 | Sodium Thiosulfate | Sodium Thiosulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PEDMARK 90071857 not registered Live/Pending |
Fennec Pharmaceuticals, Inc. 2020-07-24 |
![]() PEDMARK 87305680 not registered Live/Pending |
Fennec Pharmaceuticals, Inc. 2017-01-18 |